Mikhail Blagosklonny’s Peer Review Publication Helps Find New Treatment Methods

Mikhail Blagosklonny knows a lot about cancer and about the treatment methods that come along with cancer. He has worked hard in his oncology practice and has learned as much as he can about cancer. He has tried to do a lot of research but has, sometimes, found it hard to be able to learn about cancer and how it can affect other areas of the body. For Mikhail Blagosklonny to be able to learn about cancer treatment, he had to make sure that he was using all of the resources possible so that he could do everything right.One thing that Mikhail Blagosklonny always thought that he was missing was the ability to connect with other doctors who specialized in different types of medicine. He thought this was a missing piece and he tried to make sure that he was going to learn it but it was sometimes hard for him to connect with other doctors.

He wanted to develop a platform that would help people connect and that would allow them the chance to help each other with the treatment options that they had in their other areas. It was something that he was confident in and something that he knew he would be able to help people with.The idea that he had came and he was able to start a peer review publication. This is Oncotarget and it has been able to help people learn more about treatment and research methods. Any time that one of the members of the publication learns something new about the area that they specialize in, they are able to put it on the peer review publication. It can then be used for people who want to make sure that they are doing things the right way and people who want to be able to learn more about the issues in other areas of medicine.

While Mikhail Blagosklonny has been doing all of this, he has been collecting information on the treatment methods. One other specialist recently showed him that he would be able to make things better for all of his patients. He wanted to show them that they were getting everything that they could and he wanted to make sure that his patients were able to be healthy when they came out of cancer treatment. He also wanted to make sure that they were not going to be killed by the treatment that he was trying to use to keep them from dying.Since immunity can be extremely low while people are going through cancer treatment, Mikhail Blagosklonny knows that he has to do something to help this. For him, he was able to find that rejuvenation therapy worked. This therapy can be used by most cancer patients and can be easy for them to realize what they are able to do. Mikhail Blagosklonny knows that this can help people and that they will be able to make things right no matter what is going on and no matter what they are doing with their cancer treatment.

University of Chicago joins Eric Lefkofsky, CEO of Tempus to Fight Breast Cancer

Battling cancer is the most related news in the century and breast cancer, alone, is one of the most common leading causes of death. Jim Dallke, Associate Editor of Chicago Inno stated that Tempus is the cancer-fighting startup that wants to give the physicians at the University of Chicago genomic sequencing data that will change how data will influence treatment success in the future. Data is important to use in medicine due to statistics, patterns and molecular spreadsheets.

Tempus Partnership

Tempus`s founder Eric Lefkofsky started partnering with University of Chicago Medicine in 2015 and this year the project is taking off. This alliance is bound to provide data used to change treatment plans. The data sequencing will be used to monitor how patients respond to treatment plans. Genetic information isn`t sequenced enough so that physicians can improve treatment decisions, so the molecular data being processed will increase positive patient outcomes. Tempus steadily impacts the healthcare society and strives to accelerate private institutions order of science so that patients can go home to their families. Lefkosfy`s numerous community ventures started in Chicago, his hometown in which are initial startups called Groupon, Lightbank, and Drivin.

Who is Eric Lefkofsky?

Eric Lefkofsky graduated from the University of Michigan and is the CEO of Tempus and co-founder of several companies such as Groupon, Echo Global Logistics, InnerWorkings, Mediaocean and Uptake. He supports several ongoing charities by creating, buying and selling companies then giving a portion of that money back to the communities such as health, education, human rights, arts and culture. Lefkofsky`s confidence in business partnerships strengthens our outlook on the future of fighting cancer once and for all.

Lefkofsky’s Ideas

As he continues to change lives, accelerated disruption is proving to be one of his best idea for positive business outcomes for doctors, colleges, patient services and overall research science.